A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-0181
Full Text
Open PDFAbstract
Available in full text
Date
August 9, 2012
Authors
Publisher
American Association for Cancer Research (AACR)